Patent · US Active

Solid forms of treprostinil

US10167247B2 · kind B2 · utility

7Cited by

44References

42Claims

0Family size

Assignee

United Therapeutics Corporation · US

Inventors

Kenneth R. Phares · Chapel Hill, US
Michael Scannell · Holly Springs, US

Key dates

Filing date	Oct 25, 2017
Grant date	Jan 1, 2019
Priority date	—
Expiry date	Oct 25, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C51/412
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided individual polymorphic forms of treprostinil and pharmaceutical formulations comprising the same, methods of making and using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.